Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Feb:54:7-11.
doi: 10.1016/j.gde.2019.02.003. Epub 2019 Mar 4.

Organoid models for translational pancreatic cancer research

Hervé Tiriac  1 , Dennis Plenker  2 , Lindsey A Baker  2 , David A Tuveson  3
Affiliations
Review

Organoid models for translational pancreatic cancer research

Hervé Tiriac et al. Curr Opin Genet Dev. 2019 Feb.

Abstract

Despite recent advances in the treatment of cancer, pancreatic ductal adenocarcinoma (PDAC) still retains the worst survival rate of common malignancies. Late diagnosis and lack of curative therapeutic options are the most pressing clinical problems for this disease. Therefore, there is a need for patient models and biomarkers that can be applied in the clinic to identify the most effective therapy for a patient. Pancreatic ductal organoids are ex-vivo models of PDAC that can be established from very small biopsies, enabling the study of localized, advanced, and metastatic patients. Organoids models have been applied to pancreatic cancer research and offer a promising platform for precision medicine approaches.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Patient-derived organoids and stromal cells, such as immune cells and cancer associated fibroblasts, can be isolated from small and large tissue samples. Organoids cultures can recapitulate clonal heterogeneity of the neoplastic tissue. the Molecular (DNA/RNA) and phenotypic (drug testing) characterization of mono- and co-culture systems can provide actionable clinical insights for cancer patients at all stages of the disease.
See this image and copyright information in PMC

References

    1. Siegel RL, Miller KD, and Jemal A, Cancer statistics, 2018. CA Cancer J Clin, 2018. 68(1): p. 7–30. - PubMed
    1. Khorana AA, et al., Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol, 2016. 34(21): p. 2541–56. - PubMed
    1. Winter JM, et al., 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J Gastrointest Surg, 2006. 10(9): p. 1199–210; discussion 1210-1. - PubMed
    1. Groot VP, et al., Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma. Ann Surg, 2017. - PubMed
    1. Neoptolemos JP, et al., Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet, 2017. 389(10073): p. 1011–1024. - PubMed

Publication types

MeSH terms